Insurance coverage is integral to the accessibility, use, and ultimate impact of digital therapeutics. Inconsistency of decision-making across payors contributes to variable insurance coverage and unequal access to DTx products.
DTA’s Payor Accelerator Board (PAB) is providing critical insight into how payors decide on coverage to develop resources and publications to inform research, evidence generation, and clinical adoption of new technologies. Board members represent key stakeholders, including:
- Leading national and regional private insurer plans
- Business groups representing large, self-insured employers
- Experts in public payor policies
Olivia Brandt
Director, Health and Benefits
Willis Tower Watson
Herk Confer
VP Optum Labs
UnitedHealth Group
Nick Dougherty
VP, Digital
Allways Health Partners
Steve Driver
Medical Director of Digital Therapeutics
Advocate Aurora Health
Sander Koyfman
Chief Medical Officer
Athena Psych
Cody Midlam
Associate Director – Rx Collaborative
Willis Tower Watson
Jason Parent
Director of Clinical Innovation
Point32 Health
Mark Rakowski
Chief Operating Officer
Children’s Community Health Plan
Russell Spjut
Director of Formulary Management
Magellan
Jon Vecchiet
PharmD Director, Clinical Pharmacy Operations
Oscar Health